← Eichor
Condition: Hepatocellular Carcinoma Synced from ClinicalTrials.gov · July 27, 2026

Recruiting studies: Hepatocellular Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07224750Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular Carcinoma
Phase 1 · 2 location(s) · Zhejiang University · NCT06461624Lenvatinib+Sintilimab+TACE vs. Lenvatinib+TACE for Advanced HCC
Phase 3 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT05608200TIPS Plus Cadonilimab in Advanced HCC with Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Ph
Phase 2 · 1 location(s) · Fei Gao · NCT05882370Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma
Phase 2/Phase 3 · 3 location(s) · University Hospital, Basel, Switzerland · NCT07302919A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocel
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05394259Sapu003 in Advanced mTOR-sensitive Solid Tumors
Phase 1 · 1 location(s) · SAPU NANO (US) LLC · NCT07369505A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · 62 location(s) · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNA
NA · 1 location(s) · University Hospital, Rouen · NCT05375370Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCC
Phase 2 · 1 location(s) · Shunda Du · NCT07639138Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment
Phase 1 · 1 location(s) · Lee's Pharmaceutical Limited · NCT06374485A Study of SHR-2524 Plus Bevacizumab in the First-line Treatment of Advanced Hepatocellular Carcinoma
Phase 1 · 2 location(s) · Suzhou Suncadia Biopharmaceuticals Co., Ltd. · NCT07478302A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Meth
Phase N/A · 1 location(s) · Centro di Riferimento Oncologico - Aviano · NCT06028724TACE With Thermosensitive Nanogel Versus Embosphere for HCC
NA · 1 location(s) · Zhongda Hospital · NCT06593964Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma
NA · 1 location(s) · Sun Yat-sen University · NCT06550921Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT05269381Clinical Trial of Autologous CD19 CAR-T Cells (CNCT19) Therapy for Advanced Hepatocellular Carcinoma
Phase 1 · 2 location(s) · Zhejiang University · NCT06676982Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabili
Phase 2 · 1 location(s) · AHS Cancer Control Alberta · NCT05451043A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectab
Phase 1/Phase 2 · 21 location(s) · Tvardi Therapeutics, Incorporated · NCT05440708A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma
Phase 2 · 1 location(s) · Fudan University · NCT07328009Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma ,
Phase N/A · 1 location(s) · Daniel Keizman · NCT07485114Liver Cancer Disparities in American Indian and Alaska Native Persons
Phase 2 · 1 location(s) · University of Washington · NCT05304234Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients
Phase N/A · 3 location(s) · University of California, San Diego · NCT05705219Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Phase 1 · 3 location(s) · BioEclipse Therapeutics · NCT04282044Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk
Phase 2 · 7 location(s) · Northwestern University · NCT05620771NIS on the Benefits of TIPS in Patients With HCC Receiving Atezo+Bev in 1st-Line Therapy
Phase N/A · 1 location(s) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhau · NCT07365930Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Phase 1/Phase 2 · 21 location(s) · Children's Oncology Group · NCT04851119Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Longitudinal Monitoring MRD Based on ctDNA
Phase N/A · 7 location(s) · Zhujiang Hospital · NCT06157060Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based o
Phase N/A · 1 location(s) · Zhongda Hospital · NCT06849180Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma
Phase 3 · 1 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT03895359
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.